Yash Upadhyaya, BQ Prime

Yash Upadhyaya

BQ Prime

Mumbai, MH, India

Contact Yash

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

  • Unknown
  • BQ Prime

Past articles by Yash:

In Charts: What Technicals Are Saying About Indian Markets

The Nifty 50 may rally further in the coming days, riding on the momentum from the previous two weeks amid reports of a potential Covid-19 vaccine and positive domestic cues. → Read More

The Mutual Fund Show: How Investors Can Counter Volatility In Samvat 2077

Indian equity markets, which fell to their lowest in three years in March following the imposition of national lockdowns amid the Covid-19 outbreak, have since not only recouped their losses but have also surpassed previous peaks so far this year. → Read More

In Charts: What Technicals Are Saying About India Market

India’s equities posted their worst drop since September for the week ended Oct. 30, tracking their global peers, as uncertainties ahead of the U.S. presidential elections and mounting coronavirus cases in Europe weighed on investor sentiment in a volatile session. → Read More

The Mutual Fund Show: How Active Funds Fared Against Benchmarks

48.39% of Indian equity large cap funds, 59.52% of ELSS funds and 82.31% of Indian composite bond funds underperformed their respective indices, in the one year through June 2020, according to the latest S&P Indices Versus Active India Scorecard that was published in a report by S&P Dow Jones Indices. → Read More

UPL Q2 Results: Profit Rises Nearly Threefold On Low Base, Growth Guidance Maintained

UPL Q2 Results 2020-21: Net profit rises threefold over the year ago to Rs 463 crore on the back of revenue that rose 14% year-on-year to Rs 8,939 crore. → Read More

In Charts: What Technicals Are Saying About Indian Markets

The S&P BSE Sensex and the Nifty 50 index gained 1.8% and 1.4%, respectively, during the week. The broader market outperformed the benchmark indices with the Nifty Midcap and Nifty Smallcap advancing 3.1% and 2.7% each. Most sectoral indices ended higher last week barring those related to information technology and pharmaceuticals. → Read More

Consumers Shed ‘Paranoia’, Back To Spending Again, Says Asian Paints CEO

Aisan Paints, India’s biggest paintmaker, has seen demand increase every month since the world’s strictest coronavirus lockdown was eased. → Read More

Analysts Raise Target Price For Asian Paints After Q2 Results

Most analysts raised their target price for Asian Paints Ltd. as demand improved and lower costs aided the paintmaker’s margin in the quarter ended September. → Read More

Kajaria Ceramics Gets At Least Two Rating Upgrades After Q2 Results

Kajaria Ceramics Q2 Results 2020-21: Net profit fell 4% year-on-year to Rs 89 crore on the back of revenue that remained flat at Rs 712.5 crore. → Read More

UPL Shares Tumble After KPMG Resigns As Auditor To Subsidiary

Shares of UPL Ltd. posted the worst intraday fall in five months after KPMG Mauritius resigned as auditor to its subsidiary UPL Corp. → Read More

Q2 Results: 10 Mid Caps To Watch Out For This Earnings Season

Analysts expect India Inc.’s earnings to improve in the quarter ended September as economic activity picked up pace after the nation eased lockdown curbs. → Read More

In Charts: What Technicals Are Saying About Indian Markets

Indian equities gained for the second straight week, closing at their highest since February, led by a rally in banking stocks and the central bank’s signals for more policy measures to support the economy. → Read More

Equity Mutual Funds See Outflow For Third Straight Month In September

Equity and equity-linked mutual fund schemes witnessed an outflow of Rs 734 crore in September compared with an outflow of Rs 4,000 crore in August, as per AMFI data. → Read More

There’s More To Syngene Stock Surge Than Remdesivir Supply Pact

Shares of Syngene International Ltd. have surged nearly threefold in the last six months, beating all benchmarks and peers, as contract drug researcher signed pacts to make a drug used in severe cases of Covid-19, scaled up capacity and added clients. → Read More

In Charts: What Technicals Are Saying About Indian Markets

Indian equity markets posted its best weekly gain in nearly four months as hopes of a fresh U.S. stimulus, positive domestic macro-economic data and further easing of restrictions on the economy buoyed investor sentiment. → Read More

The Mutual Fund Show: Why Pharma And I.T. Funds Remain Good Investment Options

While average category returns of open-ended pharma funds in the last one year have been close to 61%, those of technology funds were 34%. Both categories have managed to beat benchmarks--S&P BSE Healthcare Index and the S&P BSE Information Technology Index. → Read More

Two Factors Analysts Say Aided Auto Sales In September

Factory-gate shipments of automakers rose in the range of 12-80% over the preceding month in September, data compiled by research reports of Nomura, Emkay Global and Dolat Capital showed. → Read More

In Charts: What Technicals Are Saying About Indian Markets

Indian equities posted their worst weekly loss in nearly five months as concerns over a second wave of coronavirus infections, persistent selling by foreign investors and weak global cues weighed on investor sentiment. → Read More

Analysts’ Take On Draft Tariff Regulation For City Gas Distribution

The Petroleum and Natural Gas Regulatory Board on Wednesday notified draft regulation for determination of transportation rate for city gas distribution network and CNG segment. → Read More

Chemcon Specialty Chemicals IPO: Here’s All You Need To Know

The maker of specialty chemicals plans to raise Rs 318 crore from its three-day initial public offering which begins on Sept. 21. → Read More